Inactive Instrument

Analyst Reco. Radius Health, Inc.

Equities

RDUS

US7504692077

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

SVB Securities Adjusts Radius Health's Price Target to $10 from $7, Keeps Market Perform Rating	22-06-24	MT
BofA Securities Upgrades Radius Health to Neutral From Underperform, Sets $8 Price Target	22-06-08	MT
Goldman Trims Radius Health's Price Target to $8 From $9, Neutral Rating Reiterated	22-05-24	MT
SVB Securities Initiates Radius Health at Market Perform With $7 Price Target	22-05-23	MT
Morgan Stanley Cuts Radius Health to Underweight From Equalweight, Price Target to $7 From $18	21-12-10	MT
Today on Wall Street: Brace for a rate hike	21-12-10
ANALYST RECOMMENDATIONS : Apple, Microsoft, Oracle, Southwest Airlines, Walt Disney	21-12-10
Goldman Sachs Cuts Radius Health to Neutral From Buy, Price Target to $12 From $33	21-12-10	MT
SVB Leerink Adjusts Radius Health's Price Target to $20 from $30, Keeps Market Perform Rating	21-12-09	MT
HC Wainwright Adjusts Radius Health's Price Target to $10 From $23, Keeps Neutral Rating	21-12-09	MT
BofA Reinstates Radius Health at Underperform Rating With $16 Price Target	21-12-06	MT
HC Wainwright Adjusts Price Target on Radius Health to $23 From $26, Keeps Neutral Rating	21-11-09	MT
RADIUS HEALTH : HC Wainwright Adjusts Price Target on Radius Health to $26 from $19, Keeps Neutral Rating	21-10-21	MT
RADIUS HEALTH : SVB Leerink Adjusts Radius Health's Price Target to $29 from $26, Keeps Market Perform Rating	21-10-21	MT
RADIUS HEALTH : Goldman Sachs Adjusts Radius Health PT to $33 From $31, Maintains Buy Rating	21-10-20	MT
RADIUS HEALTH : SVB Leerink Adjusts Radius Health's Price Target to $26 from $24, Keeps Market Perform Rating	21-08-06	MT
RADIUS HEALTH : HC Wainwright Adjusts Radius Health's Price Target to $19 From $25, Maintains Neutral Rating	21-08-06	MT
RADIUS HEALTH : Morgan Stanley Adjusts Radius Health's Price Target to $20 From $19, Keeps Equal-Weight Rating	21-05-18	MT
RADIUS HEALTH : SVB Leerink Adjusts Radius Health PT to $24 From $23, Maintains Market Perform Rating	21-05-10	MT
RADIUS HEALTH : Goldman Sachs Assumes Radius Health at Buy with $33 Price Target	21-03-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Radius Health, Inc.

Equities

RDUS

US7504692077

Analyst Reco.

Filters